Abstract
We prospectively examined 100 rheumatoid arthritis (RA) patients to calculate drug compliance rates, characteristics of compliant and non-compliant patients, and changes in compliance over time. Three assessments were obtained over a one-year follow–up. Detailed drug history of RA and for concomitant disease was queried. Sedimentation rate, C-reactive protein, and rheumatoid factor values, Ritchie articular index, morning stiffness, and health assessment questionnaire were evaluated. Twenty-six patients (30.2%) were consistently compliant and 10 patients (11.6%) were consistently non-compliant. Older age was associated with a greater likelihood of compliance. Comparison of compliant and non-compliant groups revealed no statistically significant difference in distribution of gender, disease duration, and total number of pills taken for RA and/or total number of pills taken for any reason. In conclusion, compliance to drugs in RA patients is a common problem. Clinical and laboratory activity of RA had less influence on drug compliance. Older age is associated with a greater likelihood of compliance.
Similar content being viewed by others
References
Vitolins MZ, Rand CS, Rapp SR, Ribisl PM, Sevick MA (2000) Measuring adherence to behavioral and medical interventions. Control Clin Trials 21:188S–194S
Viller F, Guillemin F, Briancon S, Moum T, Suurmeijer T, van den Heuvel W (1999) Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 26:2114–2122
de Klerk E, van der Heide D, Landewe R, van der Tempel H, Urquart J, van der Linden S (2003) Patient compliance in rheumatoid arthritis, polymyalgia rheumatica and gout. J Rheumatol 30:44–54
Pullar T, Peaker S, Martin MF, Bırd HA, Feely MP (1988) The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy. Br J Rheumatol 27:381–384
Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G (1993) Is this patient taking the treatment as prescribed? JAMA 269:2779–2781
Lee P, Tan LJ (1979) Drug compliance in outpatients with rheumatoid arthritis. Aust N Z J Med 9:274–277
Kauppi M, Sokka T, Hannonen P (2005) Survey nonresponse is associated with increased mortality in patients with rheumatoid arthritis and in a community population. J Rheumatol 32:807–810
Garcia Popa-Lisseanu MG, Greisinger A, Richardson M, O’Malley KJ, Janssen NM, Marcus DM, Tagore J, Svarez-Almazor ME (2005) Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic diseases. J Rheumatol 32:913–919
Blackwell B (1972) The drug defaulter. Clin Pharmacol Ther 13:841–848
Owen SG, Friesen WT, Roberts MS, Flux W (1985) Determinants of compliance in rheumatoid arthritic patients assessed in their home environment. Br J Rheumatol 24:313–320
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tuncay, R., Eksioglu, E., Cakir, B. et al. Factors affecting drug treatment compliance in patients with rheumatoid arthritis. Rheumatol Int 27, 743–746 (2007). https://doi.org/10.1007/s00296-006-0299-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-006-0299-9